We continually ask, “Is there a better way to do this?”
That “better way” may be in creating a dosing regimen that promotes better compliance for an existing therapy, versus developing a new molecule. It might involve an innovative delivery system. It may even be manufacturing the API in-house to help deliver a more cost-effective medication.
Regardless of the solution, our approach to creating value as a partner in animal health is built on a philosophy of simplicity, sustainability, and innovation—This is reflected in the decades of experience in both human and animal health upon which Mizner Bioscience was founded—and continues to thrive.